Dr. John P. Roberts, MD
Transplant Surgery (Transplant Surgery Physician)
- Medicare participating
At a glance
- Medical school
- University of California, San Diego School of Medicine (1980)
- Years since graduation
- 46
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 76
Licensed in California since 1988, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1980Medical school: University of California, San Diego School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Transplant Surgery Physician primary
CA license G62500 (first issued 1988; current) -
Surgery Physician
CA license G62500 (first issued 1988; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UCSF Medical Center San Francisco, CA
- Mercy Hospital Bakersfield, CA
Medical groups
- UCSF Medical Group Business Services (1,598 clinicians)
- Regents of the University of California (732 clinicians)
- UCSF Dept of Surgery (215 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 76
- Services billed
- 205
- Patients’ average age
- 63
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 68 | 36 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 36 | 20 |
| Established patient office or other outpatient visit, 40-54 minutes | 27 | 26 |
| Established patient office or other outpatient visit, 30-39 minutes | 19 | 19 |
| Transplantation of donor kidney | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in San Francisco, CA | 22 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in San Francisco, CA | 20 |
| Valganciclovir Hcl | 16 |
| Omeprazole Other prescribers in San Francisco, CA | 15 |
| Tacrolimus Other prescribers in San Francisco, CA | 15 |
| Cyclosporine Modified (cyclosporine, modified) | 14 |
| Mycophenolate Mofetil Other prescribers in San Francisco, CA | 13 |
| Pantoprazole Sodium Other prescribers in San Francisco, CA | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $49,287 in research payments for these studies, mostly to the institutions running them.
- STUDY NAME#This is an observational study encompassing individuals of diverse ages, races, ethnicities, and genders. Our cohort comprises a population with 44 female participants and a mean age of 53 - 14 years. The …
Merck Sharp & Dohme LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.